For the Inventor, By the Inventor

Enter assignee name

Vancouver, WA, United States of America

Absci LLC

USPTO Granted Patents = 11

CIPO Patents = 1

EPO Patents = 5

Trademarks = 6

Forward Citations = 3

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Sean McClain (7 out of 8 patents)

Mark Valasek (6 out of 7 patents)

Philip Barish (2 out of 2 patents)

4. Berke Cagkan Toptas (2 out of 2 patents)

5. Goran Rakocevic (1 out of 3 patents)

6. Jeremy Minshull (1 out of 1 patent)

7. Andras Gruber (1 out of 13 patents)

8. Amy Doerner (1 out of 1 patent)

9. Michael Cammarata (1 out of 1 patent)

10. Tyler Nusca (1 out of 1 patent)

11. Suzanne A Sprunger (1 out of 1 patent)

12. Melissa Patterson (1 out of 1 patent)

13. Ines De Santiago Domingos De Jesus (1 out of 1 patent)

14. Daniele Biasci (1 out of 1 patent)

15. Daniele Biasci (1 out of 1 patent)

11 patents: Sort by Forward Citations

1. 12473370 - TL1A ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE (2025-11-18),

2. 12285484 - Cancer associated antibody compositions and methods of use (2025-04-29),

3. 12157766 - Cytoplasmic expression system (2024-12-03),

4. 12134655 - Cancer associated antibody compositions and methods of use (2024-11-05),

5. 11584785 - C-peptides and proinsulin polypeptides comprising the same (2023-02-21),

6. 11447781 - Host cells for use in an inducible coexpression system (2022-09-20),

7. 11371048 - Vectors for use in an inducible coexpression system (2022-06-28),

8. 11214807 - Methods for inducible expression of polypeptides (2022-01-04),

9. 10604761 - Host cells for use in an inducible coexpression system (2020-03-31),

10. 10508270 - Coordinated coexpression of thrombin (2019-12-17),

11. 9617335 - Inducible coexpression system (2017-04-11),

Absci LLC is a biotechnology company based in Vancouver, WA, specializing in the development of innovative protein therapeutics. The organization leverages its proprietary platform to enhance the discovery and production of biologics, focusing on optimizing the efficiency of drug development processes. Absci's technology integrates advanced computational methods with synthetic biology, aiming to address complex challenges in the pharmaceutical industry and improve patient outcomes through novel therapeutic solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#31 in Vancouver, WA

#629 in Washington

#27,490 in US

#51,714 in the World

Vancouver, WA, United States of America

Absci LLC

Forward Citations = 3

28 inventors:

Sean McClain (7 out of 8 patents)

Mark Valasek (6 out of 7 patents)

Philip Barish (2 out of 2 patents)

4. Berke Cagkan Toptas (2 out of 2 patents)

5. Goran Rakocevic (1 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…